Acute promyelocytic leukemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Acute promyelocytic leukemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Other Imaging Studies

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary PreventionSurgery

Secondary PreventionSurgery

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Acute promyelocytic leukemia surgery On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Acute promyelocytic leukemia surgery

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Acute promyelocytic leukemia surgery

CDC on Acute promyelocytic leukemia surgery

Acute promyelocytic leukemia surgery in the news

Blogs on Acute promyelocytic leukemia surgery

Directions to Hospitals Treating Acute promyelocytic leukemia

Risk calculators and risk factors for Acute promyelocytic leukemia surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:  Sogand Goudarzi, MD [2]

## Overview[edit | edit source]

Surgical intervention is not recommended for the management of acute promyelocytic leukemia.

## Indications[edit | edit source]

* Surgical intervention is not recommended for the management of acute promyelocytic leukemia.[1]

## Surgery[edit | edit source]

* Surgical intervention is not recommended for the management of acute promyelocytic leukemia.[1]

## References[edit | edit source]

1. ↑ 1.0 1.1 Huang J, Sun M, Wang Z, Zhang Q, Lou J, Cai Y, Chen W, Du X (November 2016). "Induction treatments for acute promyelocytic leukemia: a network meta-analysis". Oncotarget. 7 (44): 71974–71986. doi:10.18632/oncotarget.12451. PMC 5342137. PMID 27713127.